Double Blind
Showing 9976 - 10000 of >10,000
Platinum-Sensitive Ovarian Cancer in First Relapse Trial in Worldwide (Farletuzumab, Placebo)
Completed
- Platinum-Sensitive Ovarian Cancer in First Relapse
- Farletuzumab
- Placebo
-
Phoenix, Arizona
- +67 more
Aug 9, 2021
Submental Fat Trial in Seoul (MT921, Placebo)
Completed
- Submental Fat
- MT921
- Placebo
-
Seoul, Korea, Republic ofChung-ang University Hospital
Jul 28, 2020
Venous Thromboembolism Trial in Russian Federation (Dimolegin 40 mg, Dimolegin 60 mg, Fragmin)
Active, not recruiting
- Venous Thromboembolism
- Dimolegin 40 mg
- +2 more
-
Bryansk, Russian Federation
- +14 more
Apr 25, 2022
Diabetes Trial in Boston (Albiglutide 50mg, Albiglutide matching , Exenatide 10microgram)
Terminated
- Diabetes Mellitus
- Albiglutide 50mg
- +3 more
-
Boston, MassachusettsGSK Investigational Site
Oct 8, 2020
NSCLC Trial in Worldwide (Osimertinib (AZD9291) pemetrexed cisplatin or carboplatin, Placebo for osimertinib (AZD9291)
Recruiting
- Non-small Cell Lung Cancer
- Osimertinib (AZD9291) pemetrexed cisplatin or carboplatin
- Placebo for osimertinib (AZD9291) pemetrexed cisplatin or carboplatin
-
Silver Spring, Maryland
- +43 more
Aug 8, 2022
Atherosclerosis, Coronary Artery Disease, Inflammation Trial in São Paulo (Methotrexate-LDE, Placebo-LDE)
Recruiting
- Atherosclerosis
- +2 more
- Methotrexate-LDE
- Placebo-LDE
-
São Paulo, SP, Brazil
- +1 more
Nov 7, 2020
Type 1 Diabetes Trial in Mainz (Administration of BioChaperone insulin lispro reconstituted with Humalog® (IMP1), Administration
Completed
- Type 1 Diabetes
- Administration of BioChaperone insulin lispro reconstituted with Humalog® (IMP1)
- +3 more
-
Mainz, GermanyProfil GmbH
Nov 27, 2020
Diabetes Type 2, Diastolic Dysfunction, Cardiac MRI Trial in Copenhagen Ø (Liraglutide, Placebo)
Completed
- Diabetes Mellitus Type 2
- +3 more
- Liraglutide
- Placebo
-
Copenhagen Ø, DenmarkThe department of cardiology, Rigshospitalet Denmark
Jan 13, 2021
MERS (Middle East Respiratory Syndrome), MERS Trial in Sankt-Peterburg (BVRS-GamVac-Combi, )
Recruiting
- MERS (Middle East Respiratory Syndrome)
- MERS
- BVRS-GamVac-Combi
- placebo
-
Sankt-Peterburg, Russian FederationECO-Safety
Jan 13, 2021
Seborrheic Dermatitis Trial in Canada, United States (ARQ-154 foam 0.3%, ARQ-154 vehicle foam)
Completed
- Seborrheic Dermatitis
- ARQ-154 foam 0.3%
- ARQ-154 vehicle foam
-
Fremont, California
- +23 more
Aug 4, 2022
Amyotrophic Lateral Sclerosis Trial in Worldwide (SAR443820, Placebo)
Recruiting
- Amyotrophic Lateral Sclerosis
- SAR443820
- Placebo
-
La Jolla, California
- +54 more
Feb 1, 2023
Colorectal Cancer Metastatic, Myelosuppression-Adult, Chemotherapeutic Toxicity Trial in Worldwide (Trilaciclib, Placebo)
Active, not recruiting
- Colorectal Cancer Metastatic
- +2 more
- Trilaciclib
- Placebo
-
Tucson, Arizona
- +81 more
Jan 3, 2023
Severe Acute Mucositis, Head Neck Cancer Trial in Montpellier (Oral Impact, Placebo)
Completed
- Severe Acute Mucositis
- Head and Neck Cancer
- Oral Impact
- Placebo
-
Montpellier, FranceInstitut du Cancer de Montpellier - Val d'Aurelle
Aug 11, 2020
Healthy Infants Trial in China (New infant formula with synbiotics, Standard infant formula with prebiotics)
Completed
- Healthy Infants
- New infant formula with synbiotics
- Standard infant formula with prebiotics
-
Beijing, Beijing, China
- +5 more
Feb 24, 2021
T2DM (Type 2 Diabetes) Trial in Seoul (DWP16001)
Enrolling by invitation
- T2DM (Type 2 Diabetes Mellitus)
-
Seoul, Korea, Republic ofDaewoong pharmatceutical
Nov 12, 2020
Nocturia Trial in Winston-Salem (SER120, Placebo)
Completed
- Nocturia
- SER120
- Placebo
-
Winston-Salem, North CarolinaPiedmont Medical Research Assoc.
Aug 28, 2020
Type2diabetes, Diabetic Kidney Disease Trial (Investigational Product - MIB 626, Placebo)
Not yet recruiting
- Type2diabetes
- Diabetic Kidney Disease
- Investigational Product - MIB 626
- Placebo
- (no location specified)
Mar 6, 2023
Osteoarthritis of the Knee, Pain Trial in Worldwide (REGN5069, Matching Placebo)
Terminated
- Osteoarthritis of the Knee
- Pain
- REGN5069
- Matching Placebo
-
DeLand, Florida
- +11 more
Jun 10, 2021
Coronavirus Disease 2019 Trial in United States (Placebos, Leronlimab (700mg))
Active, not recruiting
- Coronavirus Disease 2019
- Placebos
- Leronlimab (700mg)
-
Alexander City, Alabama
- +17 more
Jan 13, 2022
Healthy Volunteers Trial in Melbourne (Cohort 1: AR882 or , Cohort 2: AR882 or , Cohort 3: AR882 or )
Completed
- Healthy Volunteers
- Cohort 1: AR882 or placebo
- +3 more
-
Melbourne, Victoria, AustraliaNucleus Network Pty, Ltd.
Nov 12, 2020